Kit formulation of Bevacizumab, an anti-VEGF monoclonal antibody, and consequent labelling with Rhenium-188: initial in vitro and in vivo studies

被引：0

作者：

Bouziotis, P. ^{[1
]}

Gourni, E. ^{[1
]}

Xanthopoulos, S. ^{[1
]}

Paravatou, M. ^{[1
]}

Syrigos, K. ^{[2
]}

Loudos, G. ^{[3
]}

Archimandritis, S. C. ^{[1
]}

Varvarigou, A. D. ^{[1
]}

Harris, A. L. ^{[4
]}

机构：

[1] NCSR Demokritos, Inst Radioisotopes & Radiodiagnost Prod, Athens, Greece

[2] Sotiria Gen Hosp, Dept Med 3, Med Oncol Unit, Athens, Greece

[3] Technol Educ Inst Athens, Dept Med Instruments Technol, Athens, Greece

[4] Univ Oxford, Inst Mol Med, Mol Oncol Lab, Oxford, England

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2008年 / 35卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：S320 / S321

页数：2

共 48 条

[31] HUMANISED ANTI-VEGF AND ANTI-IL-6 RECEPTOR MONOCLONAL ANTIBODY SUPPRESSED IN-VIVO FLUID RETENTION IN PRIMARY EFFUSION LYMPHOMA
Goto, H.
Kudo, E.
Taura, M.
Matuda, K.
Kariya, R.
Okada, S.
EUROPEAN JOURNAL OF CANCER, 2013, 49 : S19 - S19
[32] Prediction of early antiproliferative response to anti-VEGF monoclonal antibody molecular-targeting therapy (bevacizumab) in human tumor xenograft using FLT
Zhao, Songji
Kuge, Yuji
Zhao, Yan
Takeuchi, Satoshi
Jin, Yongnan
Hatano, Toshiyuki
Kinoshita, Ichiro
Dosaka-Akita, Hirotoshi
Tamaki, Nazara
JOURNAL OF NUCLEAR MEDICINE, 2009, 50
[33] In vitro and in vivo evaluation of direct rhenium-188-labeled anti-CD52 monoclonal antibody alemtuzumab for radio immunotherapy of B-cell chronic lymphocytic leukemia
De Decker, Mario
Bacher, Klaus
Thierens, Hubert
Slegers, Guido
Dierckx, Rudi A.
De Vos, Filip
NUCLEAR MEDICINE AND BIOLOGY, 2008, 35 (05) : 599 - 604
[34] Labeling of the anti-melanoma 14f7 monoclonal antibody with rhenium-188-MAG3 chelate: Conjugation optimization, in vitro stability and animal studies
J. L Crudo
M. M. Edreira
E. R. Obenaus
S. G. de Castiglia
Journal of Radioanalytical and Nuclear Chemistry, 2004, 261 : 337 - 342
[35] Labeling of the anti-melanoma 14f7 monoclonal antibody with rhenium-188-MAG3 chelate:: Conjugation optimization, in vitro stability and animal studies
Crudo, JL
Edreira, MM
Obenaus, ER
de Castiglia, SG
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2004, 261 (02) : 337 - 342
[36] Phase I study of anti-PlGF monoclonal antibody (mAb) RO5323441 (RO) and anti-VEGF mab bevacizumab (BV) in patients with recurrent glioblastoma (GBM).
Lassen, Ulrik Niels
Chinot, Oliver L.
McBain, Catherine
Sorensen, Morten
Larsen, Vibeke Andree
Barrie, Maryline
Roth, Patrick
Krieter, Oliver
Wang, Karen
Habben, Kai
Tessier, Jean
Lahr, Angelika
Whiley, Matt
Weller, Michael
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[37] Blood eosinophil levels, proteomics patterns of strail and CXCL8, correlated survival with bevacizumab (anti-VEGF monoclonal antibody) treated stage-4 colon cancers
Yalcin, A. D.
Strauss, L. G.
Deveci, B.
Genc, G. E.
Savas, B.
Goktas, I
Bisgin, A.
Kargi, A.
Gumuslu, S.
ALLERGY, 2013, 68 : 592 - 592
[38] Docetaxel-loaded single-wall carbon nanohorns using anti-VEGF antibody as a targeting agent: characterization, in vitro and in vivo antitumor activity
Zhao, Qian
Li, Nannan
Shu, Chang
Li, Ruixin
Ma, Xiaona
Li, Xuequan
Wang, Ran
Zhong, Wenying
JOURNAL OF NANOPARTICLE RESEARCH, 2015, 17 (05)
[39] Docetaxel-loaded single-wall carbon nanohorns using anti-VEGF antibody as a targeting agent: characterization, in vitro and in vivo antitumor activity
Qian Zhao
Nannan Li
Chang Shu
Ruixin Li
Xiaona Ma
Xuequan Li
Ran Wang
Wenying Zhong
Journal of Nanoparticle Research, 2015, 17
[40] Durable stable disease with nivolumab, PD-1 inhibitor, and subsequent bevacizumab, Anti-VEGF monoclonal antibody, in long standing recurrent respiratory papillomatosis with lung squamous cell carcinoma
Choi, Horyun
Kim, Jinah
Lee, Yeun Ho
Kim, Leeseul
Chae, Young Kwang
CANCER RESEARCH, 2022, 82 (12)

← 1 2 3 4 5 →